Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines
More than a decade ago, the pathogenesis of AIDS was reviewed in this journal, using the subtitle ‘classical and alternative views', when evidence was accumulating that HIV could not cause AIDS simply through direct cytopathic mechanisms alone. Generalised immune activation after infection with...
Gespeichert in:
Veröffentlicht in: | Clinical medicine (London, England) England), 2008-06, Vol.8 (3), p.267-271 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 271 |
---|---|
container_issue | 3 |
container_start_page | 267 |
container_title | Clinical medicine (London, England) |
container_volume | 8 |
creator | Cadogan, Martin Dalgleish, Angus G |
description | More than a decade ago, the pathogenesis of AIDS was reviewed in this journal, using the subtitle ‘classical and alternative views', when evidence was accumulating that HIV could not cause AIDS simply through direct cytopathic mechanisms alone. Generalised immune activation after infection with HIV is now understood to be associated with and predictive of disease progression and probably represents the single most important difference between rapid progression and slow or non-progression. However, the fundamental source of this phenomenon remains undetermined. Do pathogenic events after acute infection promote an environment susceptible to increased hyperactivity or does inherent reactivity towards HIV in susceptible individuals ultimately influence these processes? New strategies aimed at eliminating HIV-induced immune activation are required, as is investigation into the clinical and immunological influence of antibodies that target HIV epitopes associated with disease and that are not necessarily neutralising. Therapeutic vaccines to prevent disease may be more practical and effective than classic prophylactic vaccination. |
doi_str_mv | 10.7861/clinmedicine.8-3-267 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4953827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1470211824002227</els_id><sourcerecordid>69321776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-9aa436aa280ec5fb82d82a400f7d48da9daca343b801c83998b71ff4c4a368a63</originalsourceid><addsrcrecordid>eNqFkc1rFTEUxQdR7If-ByKDoLup-ZpMxoUgxdpCQRcq7sJ9d5K-W2aSZzLz4P33pvbRVhe6SuD-7snJOVX1grOTzmj-FkcKkxsIKbgT08hG6O5RdchVJxtlevn49501gnNzUB3lfM0Yb1Wvn1YH3GihmBSH1Y8vMK_jlQsuU66jr88vvr-rQwxN3jgkT1jTNC3B1evdxiXAmbY072oIQ01zLsPNSAgzxZBrH1O9BbxxlJ9VTzyM2T3fn8fVt7OPX0_Pm8vPny5OP1w2WLzMTQ-gpAYQhjls_cqIwQhQjPluUGaAfgAEqeTKMI5G9r1Zddx7hQqkNqDlcfX-VnezrEoc6MKcYLSbRBOknY1A9s9JoLW9ilur-lYa0RWBN3uBFH8uLs92ooxuHCG4uGSreyl41-n_goILwZlWBXz1F3gdlxRKClZIrUwrRV8gdQthijkn5-8sc2ZvCrYPC7bGSlsKLmsvH373fmnfaAFe7wHICKNPEJDyHSeY0m3XyvvcXClnSy7ZjOQClgeTw9kOkf7t5Behhsol</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>236485329</pqid></control><display><type>article</type><title>Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Cadogan, Martin ; Dalgleish, Angus G</creator><creatorcontrib>Cadogan, Martin ; Dalgleish, Angus G</creatorcontrib><description>More than a decade ago, the pathogenesis of AIDS was reviewed in this journal, using the subtitle ‘classical and alternative views', when evidence was accumulating that HIV could not cause AIDS simply through direct cytopathic mechanisms alone. Generalised immune activation after infection with HIV is now understood to be associated with and predictive of disease progression and probably represents the single most important difference between rapid progression and slow or non-progression. However, the fundamental source of this phenomenon remains undetermined. Do pathogenic events after acute infection promote an environment susceptible to increased hyperactivity or does inherent reactivity towards HIV in susceptible individuals ultimately influence these processes? New strategies aimed at eliminating HIV-induced immune activation are required, as is investigation into the clinical and immunological influence of antibodies that target HIV epitopes associated with disease and that are not necessarily neutralising. Therapeutic vaccines to prevent disease may be more practical and effective than classic prophylactic vaccination.</description><identifier>ISSN: 1470-2118</identifier><identifier>EISSN: 1473-4893</identifier><identifier>DOI: 10.7861/clinmedicine.8-3-267</identifier><identifier>PMID: 18624032</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>AIDS ; AIDS Vaccines - therapeutic use ; Animals ; Autoimmunity ; Biological and medical sciences ; General aspects ; graft-versus-host disease ; HIV ; HIV - immunology ; HIV Antibodies - immunology ; HIV Antigens - immunology ; HIV Infections - immunology ; HIV Infections - prevention & control ; HLA ; Human immunodeficiency virus ; Human viral diseases ; Humans ; immune activation ; immune evasion ; Infectious diseases ; long-term non-progressors ; Medical sciences ; Original Papers ; Prevention and actions ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>Clinical medicine (London, England), 2008-06, Vol.8 (3), p.267-271</ispartof><rights>2008 © 2008 THE AUTHORS. Published by Elsevier Limited on behalf of the Royal College of Physicians.</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Royal College of Physicians Jun 2008</rights><rights>2008 Royal College of Physicians 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-9aa436aa280ec5fb82d82a400f7d48da9daca343b801c83998b71ff4c4a368a63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4953827/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4953827/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20465753$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18624032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cadogan, Martin</creatorcontrib><creatorcontrib>Dalgleish, Angus G</creatorcontrib><title>Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines</title><title>Clinical medicine (London, England)</title><addtitle>Clin Med (Lond)</addtitle><description>More than a decade ago, the pathogenesis of AIDS was reviewed in this journal, using the subtitle ‘classical and alternative views', when evidence was accumulating that HIV could not cause AIDS simply through direct cytopathic mechanisms alone. Generalised immune activation after infection with HIV is now understood to be associated with and predictive of disease progression and probably represents the single most important difference between rapid progression and slow or non-progression. However, the fundamental source of this phenomenon remains undetermined. Do pathogenic events after acute infection promote an environment susceptible to increased hyperactivity or does inherent reactivity towards HIV in susceptible individuals ultimately influence these processes? New strategies aimed at eliminating HIV-induced immune activation are required, as is investigation into the clinical and immunological influence of antibodies that target HIV epitopes associated with disease and that are not necessarily neutralising. Therapeutic vaccines to prevent disease may be more practical and effective than classic prophylactic vaccination.</description><subject>AIDS</subject><subject>AIDS Vaccines - therapeutic use</subject><subject>Animals</subject><subject>Autoimmunity</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>graft-versus-host disease</subject><subject>HIV</subject><subject>HIV - immunology</subject><subject>HIV Antibodies - immunology</subject><subject>HIV Antigens - immunology</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - prevention & control</subject><subject>HLA</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>immune activation</subject><subject>immune evasion</subject><subject>Infectious diseases</subject><subject>long-term non-progressors</subject><subject>Medical sciences</subject><subject>Original Papers</subject><subject>Prevention and actions</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>1470-2118</issn><issn>1473-4893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkc1rFTEUxQdR7If-ByKDoLup-ZpMxoUgxdpCQRcq7sJ9d5K-W2aSZzLz4P33pvbRVhe6SuD-7snJOVX1grOTzmj-FkcKkxsIKbgT08hG6O5RdchVJxtlevn49501gnNzUB3lfM0Yb1Wvn1YH3GihmBSH1Y8vMK_jlQsuU66jr88vvr-rQwxN3jgkT1jTNC3B1evdxiXAmbY072oIQ01zLsPNSAgzxZBrH1O9BbxxlJ9VTzyM2T3fn8fVt7OPX0_Pm8vPny5OP1w2WLzMTQ-gpAYQhjls_cqIwQhQjPluUGaAfgAEqeTKMI5G9r1Zddx7hQqkNqDlcfX-VnezrEoc6MKcYLSbRBOknY1A9s9JoLW9ilur-lYa0RWBN3uBFH8uLs92ooxuHCG4uGSreyl41-n_goILwZlWBXz1F3gdlxRKClZIrUwrRV8gdQthijkn5-8sc2ZvCrYPC7bGSlsKLmsvH373fmnfaAFe7wHICKNPEJDyHSeY0m3XyvvcXClnSy7ZjOQClgeTw9kOkf7t5Behhsol</recordid><startdate>20080601</startdate><enddate>20080601</enddate><creator>Cadogan, Martin</creator><creator>Dalgleish, Angus G</creator><general>Elsevier Ltd</general><general>Royal College of Physicians</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080601</creationdate><title>Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines</title><author>Cadogan, Martin ; Dalgleish, Angus G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-9aa436aa280ec5fb82d82a400f7d48da9daca343b801c83998b71ff4c4a368a63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>AIDS</topic><topic>AIDS Vaccines - therapeutic use</topic><topic>Animals</topic><topic>Autoimmunity</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>graft-versus-host disease</topic><topic>HIV</topic><topic>HIV - immunology</topic><topic>HIV Antibodies - immunology</topic><topic>HIV Antigens - immunology</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - prevention & control</topic><topic>HLA</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>immune activation</topic><topic>immune evasion</topic><topic>Infectious diseases</topic><topic>long-term non-progressors</topic><topic>Medical sciences</topic><topic>Original Papers</topic><topic>Prevention and actions</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cadogan, Martin</creatorcontrib><creatorcontrib>Dalgleish, Angus G</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>UK & Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical medicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cadogan, Martin</au><au>Dalgleish, Angus G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines</atitle><jtitle>Clinical medicine (London, England)</jtitle><addtitle>Clin Med (Lond)</addtitle><date>2008-06-01</date><risdate>2008</risdate><volume>8</volume><issue>3</issue><spage>267</spage><epage>271</epage><pages>267-271</pages><issn>1470-2118</issn><eissn>1473-4893</eissn><abstract>More than a decade ago, the pathogenesis of AIDS was reviewed in this journal, using the subtitle ‘classical and alternative views', when evidence was accumulating that HIV could not cause AIDS simply through direct cytopathic mechanisms alone. Generalised immune activation after infection with HIV is now understood to be associated with and predictive of disease progression and probably represents the single most important difference between rapid progression and slow or non-progression. However, the fundamental source of this phenomenon remains undetermined. Do pathogenic events after acute infection promote an environment susceptible to increased hyperactivity or does inherent reactivity towards HIV in susceptible individuals ultimately influence these processes? New strategies aimed at eliminating HIV-induced immune activation are required, as is investigation into the clinical and immunological influence of antibodies that target HIV epitopes associated with disease and that are not necessarily neutralising. Therapeutic vaccines to prevent disease may be more practical and effective than classic prophylactic vaccination.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>18624032</pmid><doi>10.7861/clinmedicine.8-3-267</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1470-2118 |
ispartof | Clinical medicine (London, England), 2008-06, Vol.8 (3), p.267-271 |
issn | 1470-2118 1473-4893 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4953827 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | AIDS AIDS Vaccines - therapeutic use Animals Autoimmunity Biological and medical sciences General aspects graft-versus-host disease HIV HIV - immunology HIV Antibodies - immunology HIV Antigens - immunology HIV Infections - immunology HIV Infections - prevention & control HLA Human immunodeficiency virus Human viral diseases Humans immune activation immune evasion Infectious diseases long-term non-progressors Medical sciences Original Papers Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
title | Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T07%3A41%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathogenesis%20of%20HIV:%20non-specific%20immune%20hyperactivity%20and%20its%20implications%20for%20vaccines&rft.jtitle=Clinical%20medicine%20(London,%20England)&rft.au=Cadogan,%20Martin&rft.date=2008-06-01&rft.volume=8&rft.issue=3&rft.spage=267&rft.epage=271&rft.pages=267-271&rft.issn=1470-2118&rft.eissn=1473-4893&rft_id=info:doi/10.7861/clinmedicine.8-3-267&rft_dat=%3Cproquest_pubme%3E69321776%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=236485329&rft_id=info:pmid/18624032&rft_els_id=S1470211824002227&rfr_iscdi=true |